Literature DB >> 27742809

A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillation.

Daniel F Gudbjartsson1,2, Hilma Holm3,4, Patrick Sulem3, Gisli Masson3, Asmundur Oddsson3, Olafur Th Magnusson3, Jona Saemundsdottir3, Hafdis Th Helgadottir3, Hannes Helgason3, Hrefna Johannsdottir3, Solveig Gretarsdottir3, Sigurjon A Gudjonsson3, Inger Njølstad5, Maja-Lisa Løchen5,6, Larry Baum7, Ronald C W Ma8, Gunnlaugur Sigfusson9, Augustine Kong3,2, Guðmundur Thorgeirsson4,10, Jon Th Sverrisson11, Unnur Thorsteinsdottir3,10, Kari Stefansson3,10, David O Arnar1,4,10.   

Abstract

AIMS: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in man, causing substantial morbidity and mortality with a major worldwide public health impact. It is increasingly recognized as a highly heritable condition. This study aimed to determine genetic risk factors for early-onset AF. METHODS AND
RESULTS: We sequenced the whole genomes of 8453 Icelanders and imputed genotypes of the 25.5 million sequence variants we discovered into 1799 Icelanders with early-onset AF (diagnosed before 60 years of age) and 337 453 controls. Each sequence variant was tested for association based on multiplicative and recessive inheritance models. We discovered a rare frameshift deletion in the myosin MYL4 gene (c.234delC) that associates with early-onset AF under a recessive mode of inheritance (allelic frequency = 0.58%). We found eight homozygous carriers of the mutation, all of whom had early-onset AF. Six of the homozygotes were diagnosed by the age of 30 and the remaining two in their 50s. Three of the homozygotes had received pacemaker implantations due to sick sinus syndrome, three had suffered an ischemic stroke, and one suffered sudden cardiac death.
CONCLUSIONS: Through a population approach we found a loss of function mutation in the myosin gene MYL4 that, in the homozygous state, is completely penetrant for early-onset AF. The finding may provide novel mechanistic insight into the pathophysiology of this complex arrhythmia. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Early onset; Genetics; Sarcomere

Mesh:

Substances:

Year:  2016        PMID: 27742809     DOI: 10.1093/eurheartj/ehw379

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  26 in total

1.  Early sarcomere and metabolic defects in a zebrafish pitx2c cardiac arrhythmia model.

Authors:  Michelle M Collins; Gustav Ahlberg; Camilla Vestergaard Hansen; Stefan Guenther; Rubén Marín-Juez; Anna M Sokol; Hadil El-Sammak; Janett Piesker; Ylva Hellsten; Morten S Olesen; Didier Y R Stainier; Pia R Lundegaard
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-08       Impact factor: 11.205

Review 2.  Left Atrial Cardiomyopathy - A Challenging Diagnosis.

Authors:  Fabienne Kreimer; Michael Gotzmann
Journal:  Front Cardiovasc Med       Date:  2022-06-30

Review 3.  Genetic and non-genetic risk factors associated with atrial fibrillation.

Authors:  Lindsay J Young; Steve Antwi-Boasiako; Joel Ferrall; Loren E Wold; Peter J Mohler; Mona El Refaey
Journal:  Life Sci       Date:  2022-04-03       Impact factor: 6.780

4.  A Missense Variant in PLEC Increases Risk of Atrial Fibrillation.

Authors:  Rosa B Thorolfsdottir; Gardar Sveinbjornsson; Patrick Sulem; Anna Helgadottir; Solveig Gretarsdottir; Stefania Benonisdottir; Audur Magnusdottir; Olafur B Davidsson; Sridharan Rajamani; Dan M Roden; Dawood Darbar; Terje R Pedersen; Marc S Sabatine; Ingileif Jonsdottir; David O Arnar; Unnur Thorsteinsdottir; Daniel F Gudbjartsson; Hilma Holm; Kari Stefansson
Journal:  J Am Coll Cardiol       Date:  2017-10-24       Impact factor: 24.094

Review 5.  Genetics of atrial fibrillation.

Authors:  Jitae A Kim; Mihail G Chelu; Na Li
Journal:  Curr Opin Cardiol       Date:  2021-05-01       Impact factor: 2.161

6.  Genetic insight into sick sinus syndrome.

Authors:  Rosa B Thorolfsdottir; Gardar Sveinbjornsson; Hildur M Aegisdottir; Stefania Benonisdottir; Lilja Stefansdottir; Erna V Ivarsdottir; Gisli H Halldorsson; Jon K Sigurdsson; Christian Torp-Pedersen; Peter E Weeke; Søren Brunak; David Westergaard; Ole B Pedersen; Erik Sorensen; Kaspar R Nielsen; Kristoffer S Burgdorf; Karina Banasik; Ben Brumpton; Wei Zhou; Asmundur Oddsson; Vinicius Tragante; Kristjan E Hjorleifsson; Olafur B Davidsson; Sridharan Rajamani; Stefan Jonsson; Bjarni Torfason; Atli S Valgardsson; Gudmundur Thorgeirsson; Michael L Frigge; Gudmar Thorleifsson; Gudmundur L Norddahl; Anna Helgadottir; Solveig Gretarsdottir; Patrick Sulem; Ingileif Jonsdottir; Cristen J Willer; Kristian Hveem; Henning Bundgaard; Henrik Ullum; David O Arnar; Unnur Thorsteinsdottir; Daniel F Gudbjartsson; Hilma Holm; Kari Stefansson
Journal:  Eur Heart J       Date:  2021-05-21       Impact factor: 29.983

Review 7.  Genetics of atrial fibrillation-practical applications for clinical management: if not now, when and how?

Authors:  Shinwan Kany; Bruno Reissmann; Andreas Metzner; Paulus Kirchhof; Dawood Darbar; Renate B Schnabel
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

8.  Enrichment of loss-of-function and copy number variants in ventricular cardiomyopathy genes in 'lone' atrial fibrillation.

Authors:  Julieta Lazarte; Zachary W Laksman; Jian Wang; John F Robinson; Jacqueline S Dron; Emma Leach; Janet Liew; Adam D McIntyre; Allan C Skanes; Lorne J Gula; Peter Leong-Sit; Henian Cao; Brett Trost; Stephen W Scherer; Robert A Hegele; Jason D Roberts
Journal:  Europace       Date:  2021-06-07       Impact factor: 5.214

Review 9.  Update on Biomarkers Associated to Cardioembolic Stroke: A Narrative Review.

Authors:  Ana Catarina Fonseca; Pedro Coelho
Journal:  Life (Basel)       Date:  2021-05-17

Review 10.  Atrial fibrillation-a complex polygenetic disease.

Authors:  Julie H Andersen; Laura Andreasen; Morten S Olesen
Journal:  Eur J Hum Genet       Date:  2020-12-05       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.